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Assessment of risk of insect-resistant transgenic 
crops to nontarget arthropods
Jörg Romeis1, Detlef Bartsch2, Franz Bigler1, Marco P Candolfi3,19, Marco M C Gielkens4, Susan E Hartley5, 
Richard L Hellmich6, Joseph E Huesing7, Paul C Jepson8, Raymond Layton9, Hector Quemada10, 
Alan Raybould11, Robyn I Rose12, Joachim Schiemann13, Mark K Sears14, Anthony M Shelton15, 
Jeremy Sweet16, Zigfridas Vaituzis17 & Jeffrey D Wolt18
An international initiative is developing a scientifically rigorous 
approach to evaluate the potential risks to nontarget arthropods 
(NTAs) posed by insect-resistant, genetically modified (IRGM) 
crops. It adapts the tiered approach to risk assessment 
that is used internationally within regulatory toxicology and 
environmental sciences. The approach focuses on the formulation 
and testing of clearly stated risk hypotheses, making maximum 
use of available data and using formal decision guidelines 
to progress between testing stages (or tiers). It is intended 
to provide guidance to regulatory agencies that are currently 
developing their own NTA risk assessment guidelines for IRGM 
crops and to help harmonize regulatory requirements between 
different countries and different regions of the world.
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IRGM crops that express Cry proteins derived from the soil bacterium 
Bacillus thuringiensis (Bt) have been grown in several countries on a 
steadily increasing acreage since their introduction in 1996. In 2006, 
transgenic varieties of cotton and maize that express Bt proteins were 
grown on 32.1 million hectares worldwide1. Several crops expressing 
novel insecticidal proteins are also under development and these are 
expected to be commercialized in the near future. (Although insecti-
cidal traits associated with commercialized genetically modified (GM) 
crops have all been proteins, we recognize that future traits might not 
necessarily be restricted to this class of molecule.) In common with 
conventional agricultural pest control products (which include syn-
thetic and organic insecticides, biological control agents and host-plant 
resistance developed by conventional breeding), one of the risks asso-
ciated with the growing of IRGM crops is their potential to adversely 
affect nontarget organisms. These include a range of arthropod species 
that fulfill important ecological functions such as biological control, 
pollination and decomposition. The potential for adverse effects of 
IRGM crops on these NTAs has been evaluated as part of the envi-
ronmental risk assessment (ERA) process that takes place before the 
decision to cultivate these crops commercially2,3. The relative novelty of 
IRGM crops and the complexity and sophistication of ERA procedures 
present regulatory authorities with a challenge when they are required 
to develop appropriate risk assessment methodologies. This is a par-
ticularly difficult task in the developing world, where the regulatory 
infrastructure is still being established.
General guidance for conducting an ERA for genetically modified 
(GM) plants exists4–9. There remains, however, a need for detailed 
descriptions for NTA risk assessment procedures, including selection 
criteria for the NTA test species and test methods that can apply to dif-
ferent regions if these general guidelines are to be adapted for specific 
crops in specific agriculture ecosystems. To address this need and to 
formulate the underlying rationale of the existing ERA approaches, 
an initiative was launched within the GM organisms working group 
of the West Palaearctic Regional Section (WPRS) of the International 
Organization for Biological and Integrated Control of Noxious Animals 
and Plants (IOBC) (http://www.iobc-wprs.org/)10. The group consists 
of European and North American scientists from public research insti-
tutes, regulatory agencies, the agricultural biotechnology industry and 
a commercial testing laboratory. The current focus of this group is the 
development of an IRGM-specific rationale for a tiered toxicological 
testing system which, when integrated with exposure, will enable poten-
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tial risks to NTAs to be defined and assessed. This is intended to provide 
regulators with a scientific rationale for the risk assessment decisions that 
they make. Ultimately, the risk management decision that regulators make 
also takes into account relevant social and political considerations11,12.
In the following article, we outline the basic principles and rationale of 
the tiered approach. We also describe the ways in which this approach has 
been refined by scientists from public, industrial and regulatory sectors, 
who have extensive experience with IRGM crops.
Problem formulation
In our approach, the problem formulation stage is designed to identify 
the areas of greatest concern or uncertainty concerning ecological risks, 
and to define the scope of the risk assessment by generating testable sci-
entific hypotheses that are subsequently addressed in the analytical phase 
of the risk assessment8,13,14. The information that is considered during 
problem formulation takes many forms, including published scientific 
literature, expert opinion, stakeholder deliberations and data developed 
by the registrants and submitted to the regulatory authority as part of the 
registration dossier. This information establishes the level of ‘familiarity’ 
(that is, the similarities in ecologically relevant characteristics) between the 
IRGM crop and nontransformed crop15–17 and, together with the related 
concept for food of ‘substantial equivalence’, serves as a starting point to 
focus the ERA process on potential stressors of concern18,19. If substantial 
equivalence and familiarity are established, the ERA can proceed with 
emphasis on narrowly defined, stressor-mediated effects that arise from 
the expressed trait in the IRGM crop (e.g., a Bt protein)14,20. In cases where 
substantial differences other than those directly related to the expressed 
trait are detected, these characteristics become additional potential stress-
ors that also need to be evaluated, following the same tiered approach that 
we outline. Thus, the greater the extent of familiarity between the IRGM 
crop and the nontransformed crop, the more specific and focused the 
risk hypotheses will be. The feedback inherent in the process described 
increases the efficiency of ERA for familiar crops and focuses resources 
on less familiar commodities as they arise.
The data commonly requested by authorities 
to satisfy regulatory assessments are particularly 
important for the establishment of familiarity 
and typically include a description of the host 
crop, the source and molecular characterization 
of the introduced genetic elements, the nature 
and stability of protein expression, the spectrum 
of protein activity, macro- and micronutrient 
composition, the content of important toxicants 
and antinutrients, and morphological and agro-
nomic plant characteristics. Regulatory agencies 
may also request the results of field trials con-
ducted at several locations that are representa-
tive of where the crop will be grown. In all cases, 
descriptions of plant characteristics, which are 
made with reference to plants that are gener-
ally regarded as environmentally ‘acceptable’, 
are used to identify meaningful differences that 
may need to be addressed in the risk assess-
ment.2,8,15,16,18. A ‘meaningful difference’, in this 
context, refers to a substance or another attribute 
previously associated with effects that may be 
of environmental concern (e.g., an unintended 
increase in alkaloid levels in GM cotton plants 
modified to express a Cry protein could affect 
NTAs). It is evident that the degree of familiarity 
with a given crop and IRGM approach and its 
conventional comparators will increase over time and with experience.
The problem formulation may result in recommendations that a nar-
rowly defined set of experimental evaluations should be undertaken for 
the risk assessment of some IRGM crops with well-known characteristics. 
This could result in criticism that the risk assessment is superficial and not 
likely to detect potential risks. However, the process explicitly considers the 
specifics of the stressor’s mode of action, spectrum of activity and levels of 
exposure of NTAs to the stressor. Data to support the problem formula-
tion may derive, for example, from the tests carried out during IRGM plant 
development. The pest activity spectrum is commonly explored during 
development by testing the activity of the insecticidal protein against a 
range of pest species belonging to different orders. Additional data may 
also exist in the literature concerning the spectrum of activity of some pro-
teins (e.g., certain Cry proteins from Bt) that have been studied by public 
sector scientists21,22. The information base that is inherent to the concept 
of familiarity is therefore considerable; thus, we argue that risk assessment 
for specific applications associated with familiar crops/traits can be both 
thorough and accurate without requiring extensive additional testing.
Problem formulation identifies scientifically analyzable endpoints that 
reflect management or protection goals that are set by public policy. For 
example, if ‘protection of biodiversity’ is the management goal, a typical 
assessment endpoint would be the abundance and species richness of 
certain groups of NTAs, such as those that fulfill important ecological 
functions. Different regulatory agencies may define different assessment 
endpoints or even have different management objectives. These must all 
be considered explicitly in the problem formulation stage so that the risk 
hypotheses can generate data that address the goals of the regulator and 
the requirements of the policy. The problem formulation should culmi-
nate in a conceptual model and analysis plan that is consistent with the 
risk hypotheses and that establishes the relationship between the stressor 
and the ecological impacts of concern (the assessment endpoints). The 
conceptual model should take into account ecological considerations that 
might affect the nature and extent of possible environmental impacts, 
including the intended scale of cultivation of the IRGM crop.
Regulatory decision and risk management
Problem
formulation
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Figure 1  Assessment continuum within a tiered scheme of ecological risk assessment. The decision 
to reject the risk hypothesis includes consideration of residual uncertainties. With increasing tiers, 
the assessment becomes more complex and realistic, with conclusions that are more specific. The 
assessment can stop at any stage during the process as soon as sufficient information has been 
compiled to address the risk hypothesis. Thus collection of data irrelevant to the risk assessment is 
minimized. N, level of risk assessment tier; NTA, nontarget arthropod.
PERSPECT IVE
©
20
08
 
N
at
ur
e 
Pu
bl
is
hi
ng
 G
ro
u
p 
 h
ttp
://
w
w
w.
n
at
ur
e.
co
m
/n
at
ur
eb
io
te
ch
no
lo
gy
NATURE BIOTECHNOLOGY  VOLUME 26   NUMBER 2   FEBRUARY 2008 205
The ERA framework and moving through it
Scientific assessment of risks from IRGM plants is conceptually similar 
to the assessment of risks from traditional synthetic insecticides even 
though insecticidal proteins expressed by GM plants may differ from 
synthetic insecticides (e.g., by mode of action, specificity, exposure 
route)23. The tiered process of toxicity testing is generally used to assess 
the nontarget effects posed by traditional insecticides24 because it is 
suitable for assisting the decision-making process in an effective and 
rigorous way. We argue that it is also the most rigorous approach, from 
both scientific and regulatory standpoints, for determining the potential 
of IRGM plants to adversely affect NTAs. Versions of this approach are 
also in current use in established regulatory systems for GM crops4,8.
A typical risk hypothesis that emerges from problem formulation 
may be that the stressor (that is, the insecticidal protein) does not harm 
NTAs at the concentration expressed in the field. The testing of this 
hypothesis frequently leads to toxicity tests on select arthropod species. 
These tests are conducted within experimental ‘tiers’ that are initiated 
with elevated dose exposure tests (e.g., at ten times the expected envi-
ronmental exposure), often using laboratory procedures with purified 
protein in artificial diets and proceeding to more realistic scenarios of 
exposure with IRGM plants if impacts exceed certain specified thresh-
old values (Fig.  1).
Examples of the risk hypotheses that are addressed at the different 
tiers are provided in Figure 1. The conceptual pathway leads from rela-
tively simple and controllable lower tier assessments to increasingly 
complex higher tier assessments. The conclusion regarding risk drawn 
at each tier will lead either to a regulatory decision after the residual 
uncertainty of the assessment has been defined or to additional investi-
gations. These need to be conducted at the appropriate tier, which could 
be any of the lower, current or higher tiers of evaluation. Throughout 
the assessment, the risk assessor needs to confirm continually that the 
problem being addressed is still appropriate and, if necessary, revisit the 
problem formulation.
Lower tier tests serve to identify potential hazards, if they exist, and are 
typically conducted in controlled laboratory conditions (Supplementary 
Note online). Lower-tier tests are designed to measure a specific end-
point (or set of endpoints) under controlled conditions using protein 
concentrations that are usually several times higher than those present 
in the field. Such studies provide a powerful means to detect hazards 
because the biological impacts of the insecticidal protein can be iso-
lated25. The tests are not meant to reflect real-world exposures but to 
increase the likelihood that a hazard will be detected should one be 
present, and so provide confidence of minimal risk should no adverse 
effect be detected. The sequence of testing continues after the initial 
elevated-dose or dose-response tests if potential hazards were detected 
(that is, the ‘no-effect’ hypothesis had to be rejected) or if unacceptable 
uncertainties about possible hazards remain (Fig. 1). For example, con-
ducting further lower tier tests in the laboratory can refine the hazard 
assessment by increasing the taxonomic breadth or local relevance of 
test species. In cases where lower tier tests detect a potential hazard (that 
is, the ‘no-effect’ hypothesis is rejected), higher tier tests, which include 
more complex semi-field (that is, under containment using live GM 
plant material) or open field tests, can then serve to confirm whether 
an effect can still be detected under more realistic rates and routes of 
exposure to the protein (Fig. 1). In cases where uncertainty about the 
risk remains after higher tier studies, one can always return to lower 
tiers to conduct additional studies, for example, by including additional 
test species (Fig. 1). In exceptional cases, higher-tier studies or studies 
Box 1  Evaluation path for Bt maize expressing Cry1Ab for nontarget arthropods
In the evaluation of Bt maize expressing Cry1Ab, entities of concern included biological control organisms belonging to, for example, the 
orders of Coleoptera (lady beetles), Neuroptera (lacewings) and Hymenoptera (parasitoid wasps), as well as pollinators such as bees (also 
Hymenoptera), decomposers such as soil arthropods (for example, springtails) and nontarget Lepidoptera. The problem formulation identified 
several risk hypotheses that were subsequently addressed in the analytical phase of the risk assessment (Fig. 2). Because analysis of the 
available precursor information revealed with sufficient certainty that the only meaningful difference between Bt maize and its nontransformed 
comparators was the expression of the 
Cry1Ab protein, early tier (worst-case) studies 
were conducted using elevated doses of 
purified protein or plant tissue. These studies 
confirmed existing knowledge (precursor 
information) that these proteins are not 
likely to affect nonlepidopteran insects (risk 
hypotheses 1–3)22,42. Testing could thus be 
terminated at this early tier. The potential 
hazard to nontarget Lepidoptera (risk 
hypothesis 4) was recognized initially but it 
was concluded that the risk is negligible43. 
Additional studies under more realistic 
exposure conditions were triggered once a 
note44 and a more comprehensive study45 
had revealed a hazard of Cry1Ab to larvae 
of the monarch butterfly. Studies were 
conducted under semi-field conditions. These 
studies concluded that the risk of Cry1Ab 
maize to monarch populations is negligible 
because larval exposure to Cry1Ab toxin 
under field conditions is low46–49 confirming 
the initial risk assessment43.
Lab
protein
Long-term lab
semi-field
(enclosed)
Lab
tissue
Field
(open)Problem
formulation
Risk
hypotheses
Precursor information
Familiarity/equivalence
• Agronomic traits
• Composition data
• History of use
Stressor characterization
• Mode of action
• Spectrum of activity
• Molecular characterization
• Expression profile
1
Biocontrol
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2
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3
Decomposers
4
Nontarget
Lepidoptera
.
.
.
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Lacewings
Parasitoid wasps
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Figure 2  Reconstruction of NTA risk assessment for Bt maize expressing Cry1Ab showing that 
different risk hypotheses require different types of data and synthesis at different tiers.
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using alternative designs may be conducted at the initial stage of the 
risk assessment process when lower tier tests are not possible. Lower tier 
tests are, however, extremely valuable to the ERA process because they are 
highly controlled, and may provide data that are broadly applicable within 
various risk assessments. It should be noted that field observations on Bt 
crops have failed to find any adverse NTA impacts that could not have been 
predicted from laboratory or small-scale field studies22,26.
Movement between tiers takes place either because the available infor-
mation is insufficient to accept the risk hypothesis of ‘no effect’ or because 
this hypothesis has been rejected. If sufficient data and experience from 
toxicological testing and exposure analyses are available to characterize 
the potential risk as being acceptable, then there is no need to undertake 
additional testing (Fig. 1). The iterative and flexible tiered testing scheme 
described herein is designed to provide the information to support a regu-
latory decision as efficiently and rigorously as possible. In cases where the 
risk hypothesis is rejected at the highest tier (Fig. 1, Tiern+x), an adverse 
impact on NTAs can occur. As a consequence, the GM variety may either 
not be authorized or the regulatory agency may require monitoring or risk 
mitigation. Alternatively, a new problem formulation may be required in 
cases where a potentially adverse outcome is found.
A key principle of the tiered process is that particular studies are con-
ducted only when they serve to reduce uncertainty in the risk assessment. 
Where no hazard or risk is detected, effective tiered processes prevent 
costly and unnecessary testing (see Supplementary Note; the lacewing 
case). Consequently, the assessment of different risk hypotheses will follow 
different evaluation paths (Box 1 and Fig. 2). The process is designed to 
optimize the expenditure of resources by identifying and defining sources 
of potential risk, thereby minimizing the collection of data that are irrel-
evant to the risk assessment.
Species selection
For practical reasons, only a small fraction of potentially exposed ter-
restrial arthropods can be considered for regulatory testing. It is there-
fore necessary to select appropriate species to serve as surrogates that 
can be tested effectively under laboratory conditions27–29. For regula-
tory testing of IRGM plants, surrogate species should be representa-
tives of ecologically and economically important NTA taxa in the crop 
and represent different ecological functions including predation and 
parasitism of pest organisms, pollination and decomposition of plant 
material27,30. Key species or guilds that are representative of different 
functional groups are known in most systems and appropriate sur-
rogates can therefore be selected. Despite recognized limitations31, the 
application of the surrogate concept is widely applied in related fields 
including regulatory toxicity testing28,29,32,33 and environmental moni-
toring34–36. In addition, the risk assessment may consider species with 
special aesthetic or cultural value or species classified as threatened or 
endangered. These species are regionally specific and can be evaluated 
within the ERA independent of their ecological function.
The most effective surrogate taxa, for example honeybees (Apis mel-
lifera), are representatives of NTA taxa that are found in many different 
crops or regions. More specific, crop-associated species may be selected 
that represent an important genus (e.g., Orius spp.), and other taxa 
may be selected that are broadly representative of whole families (e.g., 
parasitic wasps of the Ichneumonidae) or orders (e.g., Coleoptera) that 
are known to be important. Even the nontarget pest species that are 
screened for their sensitivity to the insecticidal protein during product 
development can serve as surrogates for NTAs.
Information on the stressor (e.g., protein specificity, and the pattern 
and level of expression in the plant), together with information on the 
feeding habits of the test species, which is accu-
mulated during problem formulation, must be 
considered during the selection of appropri-
ate surrogates (Box 2). In general, nontarget 
species that are related taxonomically to the 
target pests are most likely to be affected by the 
protein; thus selection of these taxa increases 
the likelihood of detecting a hazard if one 
exists. Species that are not exposed to the 
insecticidal protein do not need to be tested 
to draw a negligible-risk conclusion. Some 
additional, practical considerations include 
the ease of working with a species, the poten-
tial for unambiguous taxonomic recognition, 
the ability to rear the species in captivity, the 
availability of permanent source colonies and 
validated and accepted test methods.
The purpose of using IRGM plants is the 
same as for any other pest management tactic; 
that is, to reduce pest populations below eco-
nomic injury levels. As a result of applying the 
tactic, the abundance of pest insects should be 
significantly reduced and this will have corre-
sponding implications for those organisms that 
exploit these pests as prey and hosts. Thus, the 
potential for these indirect ecological effects 
on biological control organisms should not be 
regarded as a unique ecological risk associated 
with the IRGM crop8,18,22. Large reductions, 
however, should be expected if the pest man-
agement strategy is effective. Because IRGM 
crops are often grown in vicinity with non-GM 
Box 2  Nontarget species selection
The number and type of NTA species that need to be tested depend on the risk hypotheses 
generated during the problem formulation. The species selection will also depend on 
how much information already exists to test the hypotheses: the level and quality of 
information on the plant, the specific stressor (that is, the insecticidal protein) expressed 
(e.g., spectrum of activity, mode of action, expression level) together with information 
about the feeding habits of the NTAs. Increasing the level and quality of information 
reduces the number of risk hypotheses that will require testing.
Example 1: novel Bt maize event expressing Cry1Ab. There is a high probability, based 
upon an extensive research history, that the protein would be active only against 
Lepidoptera and that harm to NTAs in other taxonomic orders would be negligible. 
Additionally, there is a high level of familiarity with maize, the trait and the toxin from 
experience with other Cry1Ab-expressing maize events. (Event indicates a unique 
transformation of a plant by insertion of a particular transgene into its genome). Further 
testing for this novel event is not scientifically justified provided that problem formulation 
shows the expression of the Cry1Ab protein is the only relevant difference compared with 
closely related, nontransformed maize varieties and that expression levels are similar to 
those in previously evaluated events.
Example 2: novel Bt maize event expressing a Cry3 protein. Because the protein is 
targeting corn rootworms (Diabrotica spp.) and has a known specificity to Coleoptera, 
the risk assessment should focus on nontarget coleopteran species rather than species 
belonging to other taxonomic groups.
Example 3: novel Bt maize event without toxin expression in the pollen. Honeybees are 
exposed only to insecticidal proteins expressed by GM maize varieties when these are 
present in the pollen. If the proteins are not expressed in the pollen, there is no scientific 
justification for conducting feeding studies with bees or other pollen-feeding arthropods.
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crops to prevent resistance build-up by the target pest(s)37, specialist 
antagonists can persist in these ‘refuges’, in other crops and in non-crop 
habitats and retain the potential for recolonization of the IRGM crop 
area. On the basis of these considerations, regulatory testing of the spe-
cialist predators and parasitoids of target pests may not be necessary.
Study design
Once the surrogate species are selected, they should be evaluated in 
scientifically designed and validated studies to test the risk hypotheses. 
Historically, protocols developed to assess the impact of pesticides on 
NTAs38,39 formed the basis for the tests used to evaluate IRGM plants. 
These protocols were modified to account for the oral exposure path-
way and the potential for extended exposure time to plant-expressed 
insecticidal proteins40. New protocols are being developed to address the 
specific research or regulatory needs associated with IRGM risk assess-
ment. The new or modified tests often span a significant portion of the 
test insect lifespan, which is appropriate for the period of exposure to the 
toxin in the field, and may include a number of measurement endpoints 
in addition to mortality (see Supplementary Note for examples using 
these new protocols).
Conclusions
The tiered NTA testing approach presented here provides the scientific 
rationale for the ERA of IRGM crops to assist regulatory decision mak-
ing. The framework provides a well-defined and predictable pathway for 
requesting, acquiring, organizing and evaluating data. It is the consensus 
of a diverse group of stakeholders and therefore provides a basis for 
improving harmonization of international risk assessment guidelines. 
Harmonized procedures in ERA help to facilitate risk assessment data 
acceptability and provide greater scope for comparison of ecological 
effects data internationally.
The approach presented here ensures rigorous testing of clearly stated 
and relevant risk hypotheses that are linked to defined assessment end-
points while optimizing data requirements. The risk hypotheses are 
developed from current knowledge about the biology of the crop, the 
introduced trait, the receiving environment and the interactions of all 
three. It therefore makes maximum use of the existing data and aims to 
minimize collection of data that are irrelevant to the risk assessment. The 
process is intended to be efficient and rigorous, focusing the resources 
to address potential risks or uncertainties and eliminating from further 
consideration the risks that are negligible. Potential hazards are evalu-
ated with representative surrogate/indicator species that are selected 
case by case for their suitability and amenability to test relevant risk 
hypotheses.
The general approach we outline here has evolved based upon cur-
rent events and insecticidal proteins and is flexible and adaptable to 
new IRGM products. Several aspects of the approach may, however, 
have to be further developed to take account of new traits and poten-
tial risks.
First, threshold values need to be defined that trigger the advance 
to higher tiers as has been done for environmental risk assessments of 
conventional pesticides32,33. If these trigger values are not exceeded, the 
testing stops and the regulatory decision follows. The specific triggers 
applied in a given case of an ERA for IRGM plants are informed by 
expert opinion and require deliberation among risk assessors and risk 
managers, who consider the problem being evaluated and the effects 
regarded as ‘acceptable’. We recognize, however, that defining the trigger 
values is not solely a scientific question but also depends on whether 
policy-makers are concerned about under- or overestimating risks.
Second, a list of surrogate species needs to be compiled that can serve 
as a basis for selecting the most appropriate species for laboratory testing. 
The species tested should provide the most rigorous tests of the risk 
hypotheses for a particular IRGM plant in a specific agricultural and 
environmental setting.
And third, more standardized, validated test protocols for surrogate 
test species may need to be developed. These are needed to ensure data 
comparability and facilitate international regulatory acceptance.
We believe that the tiered NTA testing approach presented above 
minimizes the likelihood of false negatives, which could result in the 
release of IRGM plants with undesirable effects on NTAs and, at the 
same time, should reverse the trend of increased delays for introduc-
ing products that may be environmentally more benign than existing 
methods of pest control41.
Note: Supplementary information is available on the Nature Biotechnology website.
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